Cell therapy for advanced gastrointestinal cancers
Part of Cancer, Digestive system clinical trials.
This trial tests a new type of cell therapy (BGT007H cells) for people with advanced gastrointestinal cancers that have not responded to at least two standard treatments. The therapy uses your own immune cells that are modified to target and attack the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer of the stomach, esophagus, pancreas, or colon/rectum that has not responded to at least two standard treatments or you cannot tolerate them
- You are 18 years or older
- Your cancer has a specific target (marker) that the therapy is designed to attack
- You have at least one measurable tumor on scans
- You are in fairly good health (able to care for yourself, with adequate organ function) and do not have active infections, unstable heart problems, or untreated brain metastases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell therapy called BGT007 for people with advanced cancers of the digestive system (esophagus, stomach, pancreas, or colon) that have not responded to standard treatments. The therapy uses your own immune cells, modified to target a protein on your cancer cells.
This trial tests a new treatment using your own immune cells that are trained to attack cancer. It is for people with advanced stomach, colon, or esophageal cancer who have already tried other treatments that didn't work.
This trial tests a new cell therapy called BGT007H for people with advanced digestive tract cancers (esophagus, stomach, pancreas, or colon) that have not responded to or stopped working after at least two prior treatments. The goal is to see if this therapy can help shrink tumors or slow the disease.
This trial is testing a new cell therapy called BGT007 for people with advanced pancreatic or colorectal cancer that has not responded to other treatments. The goal is to see if this treatment can shrink tumors or slow the cancer's growth.
This trial tests an injection of your own immune cells (tumor-infiltrating lymphocytes) to see if they can fight advanced solid tumors like stomach or lung cancer. Doctors will remove one of your tumors, grow the immune cells from it, and then give them back to you.
This trial tests a new cell therapy (BGT007H) for people with advanced pancreatic cancer that has not responded to earlier treatments. The goal is to see if it is safe and can help shrink or control the cancer.
Hear when a new Gastrointestinal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.